Literature DB >> 6603934

Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin.

H H Birdsall, R D Rossen.   

Abstract

After immunization with keyhole limpet haemocyanin (KLH), increased concentrations of anti-KLH and anti-Fab' antibodies (Abs) were demonstrated in sera from 18 of 20 volunteers. In many cases, post-immunization sera contained soluble immune complexes that incorporated both anti-Fab' and 'hidden' or 'blocked' anti-KLH antibodies. The complexes containing hidden anti-KLH and blocking anti-Fab' Abs were not found in pre-immunization sera. The hidden Abs to KLH were revealed by demonstrating increases in anti-KLH activity in sera incubated previously with Fab' fragments, immobilized on plastic microtitre tray wells. Incubation with insoluble Fab' did not influence the quantity of anti-tetanus toxoid (TT) that was detected in these sera. Addition of affinity purified anti-Fab' Abs to samples, previously 'unblocked' by adsorption with immobilized Fab', depressed their anti-KLH activity to levels present before adsorption, but did not change the quantity of Abs to Dermatophytin, Trychophyton, or TT therein. These results suggest that some autoantibodies generically recognized as 'Fab' specific' have properties that are usually considered to be characteristic of autoanti-idiotypes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603934      PMCID: PMC1535675     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Individual Antigenic Specificity of Isolated Antibodies.

Authors:  H G Kunkel; M Mannik; R C Williams
Journal:  Science       Date:  1963-06-14       Impact factor: 47.728

2.  An antigen-binding capacity test for human immunoglobulin G (IgG) fragments.

Authors:  J C Cerottini
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

3.  [Method of preparation of beta-macroglobulin from human serum].

Authors:  R Masseyeff; J Gombert; J Josselin
Journal:  Immunochemistry       Date:  1965-06

4.  In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults.

Authors:  W J Koopman; R E Schrohenloher
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

5.  Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.

Authors:  R S Geha
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

6.  Receptor-blocking factor present in immune serum resembling auto-anti-idiotype antibody.

Authors:  R B Bankert; D Pressman
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

7.  Regulation of immune response by autogenous antibody against receptor.

Authors:  L Kluskens; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

8.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

9.  CELLULAR ORIGIN OF RHEUMATOID FACTOR.

Authors:  R C Mellors; R Heimer; J Corcos; L Korngold
Journal:  J Exp Med       Date:  1959-11-30       Impact factor: 14.307

10.  Thymic requirement for cyclical idiotypic and reciprocal anti-idiotypic immune responses to a T-independent antigen.

Authors:  G Kelsoe; D Isaak; J Cerny
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  7 in total

1.  Immunoglobulin response to intrapulmonary immunization of asthmatics.

Authors:  M Schuyler; C R Lyons; B Masten; D Bice
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome.

Authors:  J R Yu; E T Lennette; S Karpatkin
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  IgG binding of monoclonal anti-nuclear antibodies from MRL-lpr/lpr mice.

Authors:  D S Pisetsky; B S Darwin; C F Reich
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

4.  Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae.

Authors:  D M Musher; A Goree; R E Baughn; H H Birdsall
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.

Authors:  Shilpa Oak; Lisa K Gilliam; Mona Landin-Olsson; Carina Törn; Ingrid Kockum; Christina R Pennington; Merrill J Rowley; Michael R Christie; J Paul Banga; Christiane S Hampe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

6.  Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa.

Authors:  C Christopoulos
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

7.  Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.

Authors:  J E Persselin; R H Stevens
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.